NCT05200429

Canadian Observational Study Evaluating the Long-term IMPACT of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators on People With CF

Canadian Observational Study Evaluating the Long-term IMPACT of CFTR (Can-IMPACT CF)

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 500 (estimated)
• Sponsor: University of British Columbia · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

This observational study intends to investigate health trends and data in cystic fibrosis patients all across Canada that are receiving modulator treatment so researchers can determine if CFTR treatments are effective over a long period of time and if so, which treatments work best for each individual. The study will collect clinical data from routine standard of care, patient reported outcomes via survey data and samples for a biobank.

Conditions

• Cystic Fibrosis

Interventions

Type	Name	Description
DRUG	Trikafta	Highly Effective CFTR Modulator Therapy

Timeline

• Start date: 2021-11-01
• Primary completion: 2027-12-31
• Completion: 2027-12-31
• First posted: 2022-01-20
• Last updated: 2022-01-20

Locations

2 sites across 1 country: Canada